Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

By J. Eikelboom, S. Connolly, J. Bosch, G. Dagenais, R. Hart, O. Shestakovska, R. Diaz, M. Alings, E. Lonn, Sonia S Anand and 39 more. New England Journal of Medicine, 2017

2,009 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/0c49bda33868241a351b15bd4fe2b1286954544c

Citations in the corpus

• Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. (2018, neutral): “18 Collectively, these results show that in patients with arterial vascular disease, low dose anticoagulants and aspirin have an additive effect.”